FDA Commissioner Issues Strong Directive to Protect Patients’ Rights
In a significant move aimed at safeguarding patient rights and reducing unnecessary healthcare expenses, Tukaram Mundhe, Commissioner of the Food and Drug Administration (FDA), has directed hospitals not to compel patients to purchase medicines or medical supplies exclusively from pharmacies operating within hospital premises.
The order comes in response to numerous complaints alleging that some hospitals, particularly large private healthcare institutions, have been pressuring patients and their families to buy medicines only from their in-house medical stores. According to the FDA, such practices are not supported by law and can place an unnecessary financial burden on patients.
Speaking to reporters, Tukaram Mundhe made it clear that patients have the legal right to decide where they purchase prescribed medicines. He emphasized that no hospital or healthcare institution can force patients to obtain medicines from a specific pharmacy.
Patients Free to Buy Medicines from Any Registered Pharmacy
Explaining the decision, Mundhe said that the FDA has repeatedly received reports from patients and their relatives claiming that hospitals refuse to allow medicines purchased from outside pharmacies. In many cases, families are told that medicines must be obtained from the hospital’s own pharmacy, regardless of availability or pricing elsewhere.
The FDA commissioner clarified that such restrictions are not legally enforceable. Patients and their families are free to purchase medicines from any licensed pharmacy of their choice. This freedom includes the option to compare prices and seek more affordable alternatives when available.
He stressed that the choice of where to buy medicines is a fundamental right of consumers and should not be controlled by healthcare providers.
Action Aimed at Curbing Excessive Costs and Monopoly Practices
Many private hospitals operate their own pharmacies, creating a system where patients often have limited options. Consumer groups and patient advocates have long argued that medicines sold within hospitals can sometimes be more expensive than those available at independent pharmacies.
The FDA believes that allowing patients to purchase medicines from outside sources could help increase transparency and competition, potentially lowering treatment costs for many families.
Healthcare experts note that access to affordable medicines is a critical issue, especially for patients undergoing long-term treatment or those facing expensive medical procedures. By reinforcing patients’ freedom of choice, the new directive seeks to prevent monopolistic practices and ensure fair access to healthcare products.
Doctors Must Provide Prescriptions to Patients
Another key aspect of the FDA’s directive concerns medical prescriptions. Tukaram Mundhe stated that doctors must provide patients or their relatives with written prescriptions for required medicines.
Once a prescription is issued, patients can purchase the medicines from any registered pharmacy that offers the required products at a suitable price. If a specific brand prescribed by a doctor is unavailable, patients may also explore approved generic alternatives after consulting healthcare professionals and pharmacists.
This measure is expected to give patients greater flexibility while also encouraging informed purchasing decisions.
Hospitals Face Legal Consequences for Violations
The FDA has made it clear that the directive is not merely an advisory but an official order that healthcare institutions are expected to follow. Hospitals that continue to pressure patients into buying medicines exclusively from their internal pharmacies could face legal action.
Mundhe urged citizens to report any such incidents directly to the Food and Drug Administration. Complaints received by the department will be investigated, and hospitals found violating the rules may face strict action under applicable laws.
The commissioner said the FDA is committed to protecting patient rights and ensuring that healthcare services operate in a fair and transparent manner.
A Step Toward Greater Patient Empowerment
The latest order is being viewed as an important step toward strengthening consumer rights in the healthcare sector. By reaffirming that patients have the freedom to choose where they purchase medicines, the FDA hopes to reduce financial pressure on families and promote a more competitive and patient-friendly healthcare environment.
As hospitals adjust to the new directive, the focus is expected to remain on ensuring that medical treatment remains accessible, transparent, and centered on the needs of patients rather than commercial interests.
